OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A hollow mesoporous iron oxide nanoparticle to strengthen Fenton reaction and weaken antioxidant defense systems for high efficacy tumor ferroptosis therapy
Jing Yang, Jiaoyang Zhu, Bin Ren, et al.
Chemical Engineering Journal (2024) Vol. 497, pp. 154470-154470
Closed Access | Times Cited: 6
Jing Yang, Jiaoyang Zhu, Bin Ren, et al.
Chemical Engineering Journal (2024) Vol. 497, pp. 154470-154470
Closed Access | Times Cited: 6
Showing 6 citing articles:
Advancing glioblastoma treatment through iron metabolism: A focus on TfR1 and Ferroptosis innovations
Matías Daniel Caverzán, Luis Exequiel Ibarra
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134777-134777
Closed Access | Times Cited: 5
Matías Daniel Caverzán, Luis Exequiel Ibarra
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134777-134777
Closed Access | Times Cited: 5
Multifunctional liposome boosts glioma ferroptosis and immunotherapy through reinforcement of chemo-dynamic therapy strategy
Hongwu Chen, Jiehao Huang, Huaiming Wang, et al.
Materials Today Bio (2025), pp. 101521-101521
Open Access
Hongwu Chen, Jiehao Huang, Huaiming Wang, et al.
Materials Today Bio (2025), pp. 101521-101521
Open Access
Endogenous Iron(II) Self-Enriched Fenton Nanocatalyst via FTH1 Activity Inhibition and Iron(III) Reduction for Amplified Cancer Ferroptosis Therapy
Ying Chen, Qin Ma, Jun Zhang, et al.
Molecular Pharmaceutics (2025)
Closed Access
Ying Chen, Qin Ma, Jun Zhang, et al.
Molecular Pharmaceutics (2025)
Closed Access
Strategy of “Controllable Ions Interference” for Boosting MRI-Guided Ferroptosis Therapy of Tumors
Zhen Chang, Zhiyu Liang, Lan Yu, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Zhen Chang, Zhiyu Liang, Lan Yu, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Combining oxygen delivery and generation for targeted atherosclerosis therapy
Yujie Wang, Qun Zhou, Le Lü, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 1017-1030
Open Access
Yujie Wang, Qun Zhou, Le Lü, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 1017-1030
Open Access
Lactate/Cysteine Dual-Consuming Probiotic–Nanomedicine Biohybrid System for Enhanced Cancer Chemo-Immunotherapy
Tian‐Qiu Xie, Xiao Yan, You‐Teng Qin, et al.
Nano Letters (2024) Vol. 24, Iss. 50, pp. 16132-16142
Closed Access | Times Cited: 2
Tian‐Qiu Xie, Xiao Yan, You‐Teng Qin, et al.
Nano Letters (2024) Vol. 24, Iss. 50, pp. 16132-16142
Closed Access | Times Cited: 2
